4.5 Article

Disruption of the homeostatic balance between autoaggressive (CD4+ CD40+) and regulatory (CD4+ CD25+ FoxP3+) T cells promotes diabetes

期刊

JOURNAL OF LEUKOCYTE BIOLOGY
卷 84, 期 2, 页码 431-439

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1189/jlb.1207857

关键词

autoimmunity; homeostasis; Treg; tolerance; diabetes

资金

  1. NIDDK NIH HHS [DK-07501, R01 DK075013] Funding Source: Medline

向作者/读者索取更多资源

Although regulatory T cells (Tregs) are well described, identifying autoaggressive effector T cells has proven more difficult. However, we identified CD4(lo)CD40(+) (Th40) cells as being necessary and sufficient for diabetes in the NOD mouse model. Importantly, these cells are present in pancreata of prediabetic and diabetic NOD mice, and Th40 cells but not CD4(+) CD40(-) T cells transfer progressive insulitis and diabetes to NOD. scid recipients. Nonobese-resistant (NOR) mice have the identical T cell developmental background as NOD mice, yet they are diabetes-resistant. The seminal issue is how NOR mice remain tolerant to diabetogenic self-antigens. We show here that autoaggressive T cells develop in NOR mice and are confined to the Th40 subset. However, NOR mice maintain Treg numbers equivalent to their Th40 numbers. NOD mice have statistically equal numbers of CD4(+) CD25(+) forkhead box P3(+) intrinsic Tregs compared with NOR or nonautoimmune BALB/c mice, and NOD Tregs are equally as suppressive as NOR Tregs. A critical difference is that NOD mice develop expanded numbers of Th40 cells. We suggest that a determinant factor for autoimmunity includes the Th40: Treg ratio. Mechanistically, NOD Th40 cells have low susceptibility to Fas-induced cell death and unlike cells from NOR and BALB/c mice, have predominantly low Fas expression. CD40 engagement of Th40 cells induces Fas expression but further confers resistance to Fas-mediated cell death in NOD mice. A second fundamental difference is that NOD Th40 cells undergo much more rapid homeostatic expansion than Th40 cells from NOR mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells

Scott Best, Vi Lam, Tingting Liu, Nur Bruss, Adam Kittai, Olga V. Danilova, Susan Murray, Allison Berger, Nathan D. Pennock, Evan F. Lind, Alexey V. Danilov

Summary: Novel targeted agents in lymphoid malignancies therapy have complex immune effects, particularly through modulation of NF-kappa B signaling and T-cell function by targeting NEDD8-activating enzyme. This approach may offer potential therapeutic benefits by altering the immune response and tumor microenvironment.

LEUKEMIA (2021)

Article Oncology

Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis

Alexandra Q. Bartlett, Nathan D. Pennock, Alex Klug, Pepper Schedin

Summary: This study discusses the mechanisms of breast cancer cells invading the liver and forming metastatic niches. The research found that the process of liver involution increases liver metastasis, which is associated with unique immunological properties in the involuting liver.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Mammary collagen is under reproductive control with implications for breast cancer

Qiuchen Guo, Duanchen Sun, Alexander S. Barrett, Sonali Jindal, Nathan D. Pennock, Matthew W. Conklin, Zheng Xia, Elizabeth Mitchell, Ravikant Samatham, Naomi Mirza, Steven Jacques, Sheila Weinmann, Virginia F. Borges, Kirk C. Hansen, Pepper J. Schedin

Summary: Mammographically-detected breast density has an impact on breast cancer risk and progression, and the presence of fibrillar collagen plays a crucial role in breast density. This study investigated the physiological factors influencing collagen production in the breast. Through the analysis of gene expression in female rats, the study revealed a triphasic pattern of collagen gene regulation and reproductive state-dependent composition. The findings were confirmed in human breast tissue from premenopausal women. The study also found a correlation between the collagen gene signature and poor progression-free survival in breast cancer patients. These findings contribute to a better understanding of normal breast function, the etiology of breast density, and breast cancer risk and outcomes.

MATRIX BIOLOGY (2022)

Meeting Abstract Endocrinology & Metabolism

Reducing Autoinflammation: The Impact of T-Cell Deficiency on Atherosclerosis

Alyssa J. Shepherd, Martin Yussman, David H. Wagner, Gisela M. Vaitaitis

DIABETES (2022)

Meeting Abstract Endocrinology & Metabolism

A Novel Drug to Modulate Autoinflammation and Promote Glucose Control in Type 1 Diabetes Mellitus

David H. Wagner, Gisela M. Vaitaitis

DIABETES (2022)

Article Immunology

CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells

Ying Lu, Max Xu, Cayce E. Dorrier, Ray Zhang, Christian T. Mayer, David Wagner, Dorian B. McGavern, Richard J. Hodes

Summary: CD40 plays an essential role in driving autoimmune diseases in the central nervous system (CNS). It orchestrates distinct effector programs in dendritic cells (DCs) and B cells, leading to the activation of pathogenic T cells and the production of disease-causing antibodies, respectively.

JOURNAL OF IMMUNOLOGY (2022)

Article Immunology

Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)

Christian Curran, Gisela Vaitaitis, Dan Waid, Timothy Volmer, Enrique Alverez, David H. Wagner

Summary: Treating multiple sclerosis has been challenging, but Ocrelizumab has shown success in treating both chronic relapsing and progressive forms of the disease. In a study, it was found that TH40 cells, which are pathogenic effector T cells, increased in number during the earliest stage of multiple sclerosis (clinically isolated syndrome) and remained expanded in progressive forms of the disease. However, treatment with Ocrelizumab reduced TH40 cell numbers to healthy levels and decreased the production of inflammatory cytokines.

JOURNAL OF NEUROIMMUNOLOGY (2023)

Article Engineering, Biomedical

Nanoscale Hafnium Metal-Organic Frameworks Enhance Radiotherapeutic Effects by Upregulation of Type I Interferon and TLR7 Expression

Eunseo Choi, Madeleine Landry, Nathan Pennock, Megan Neufeld, Katherine Weinfurter, Andrea Goforth, Joshua Walker, Conroy Sun

Summary: Recent studies have shown that combination radiotherapy and immunotherapy can improve outcomes. This study explores the use of folate-modified hafnium-based metal-organic frameworks as enhancers for radiotherapy and immune activation. The combination of HfMOF-PEG-FA with imiquimod effectively stimulates the immune response and enhances the antitumor effects of radiotherapy.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Biochemistry & Molecular Biology

Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15

Gisela M. Vaitaitis, David H. Wagner Jr

Summary: CD40 signaling is an important target in autoimmunity. Blocking the CD40-CD154 pathway using monoclonal antibodies during clinical trials led to severe adverse events. A peptide called KGYY15 has shown promise in preventing type 1 diabetes and reversing hyperglycemia by normalizing effector T-cell levels. The peptide also interacts with integrins CD11a/CD18 and CD11b/CD18, complicating our understanding of the inflammatory nexus and how to prevent autoinflammation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Article Oncology

Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia

Xiaoguang Wang, Canping Chen, Dan Vuong, Sonia Rodriguez-Rodriguez, Vi Lam, Carly Roleder, Jing H. Wang, Swetha Kambhampati, Allison Berger, Nathan Pennock, Pallawi Torka, Francisco Hernandez-Ilizaliturri, Tanya Siddiqi, Lili Wang, Zheng Xia, Alexey V. Danilov

Summary: This study demonstrates that the drug pevonedistat, which targets Neddylation, directly affects CD8(+) T cells and enhances their cytotoxicity and anti-tumor activity. It also stimulates an inflammatory response in the T cells, leading to inhibited tumor growth.

LEUKEMIA (2023)

Article Oncology

Isogenic Mammary Models of Intraductal Carcinoma Reveal Progression to Invasiveness in the Absence of a Non-Obligatory In Situ Stage

Sarah M. M. Bernhardt, Elizabeth Mitchell, Stephanie Stamnes, Reuben J. Hoffmann, Andrea Calhoun, Alex Klug, Tanya D. Russell, Nathan D. Pennock, Joshua M. M. Walker, Pepper Schedin

Summary: In breast cancer, tumor cells can rapidly progress to invasive ductal carcinoma (IDC) without going through a non-invasive stage called ductal carcinoma in situ (DCIS). These mouse models that bypass the DCIS stage can aid in the study of IDC without DCIS and the development of immune therapies.

CANCERS (2023)

Article Immunology

Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition

Fernanda M. Frank, David H. Wagner Jr, Miriam Postan, Patricia B. Petray

Summary: The CD40/CD40L interaction plays a dual role in Trypanosoma cruzi infection, depending on the timing of treatment initiation. Early treatment with CD40-targeted peptide leads to uncontrolled acute infection and marked tissue damage, while late treatment improves myocardial and skeletal muscle damage.

MICROBIAL PATHOGENESIS (2023)

Article Oncology

T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia

Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Xiaoguang Wang, Tycel Phillips, Geoffrey Shouse, Allison J. Berger, Lapo Alinari, Lili Wang, Tanya Siddiqi, Nathan D. Pennock, Alexey V. Danilov

Summary: This study found that targeting SUMOylation can activate immune response in T cells and enhance the cytotoxic function of CD8 T cells, providing potential for immune therapy targeting SUMOylation in lymphoid malignancies.

MOLECULAR CANCER THERAPEUTICS (2023)

Meeting Abstract Oncology

Evaluation of a Sumoylation Inhibitor as an Intrinsic and Extrinsic Radiosensitizer

K. C. Ohaegbulam, N. D. Pennock, J. Walker

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Ablative Radiotherapy Synergizes With Protein Vaccination to Upregulate Systemic Dendritic Cell Function Within Non-Draining Lymph Nodes

N. D. Pennock, J. Walker

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

暂无数据